A randomised, double-blind, placebo-controlled, two-sequence, two-period, crossover study to evaluate the effect of SMP-028 on oral contraceptive pharmacokinetics in healthy female subjects
Latest Information Update: 10 Jul 2010
Price :
$35 *
At a glance
- Drugs SMP 028 (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Asthma; Pregnancy
- Focus Pharmacodynamics; Pharmacokinetics
- Acronyms OC-DDI
- Sponsors Dainippon Sumitomo Pharma
- 30 Jun 2010 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials record.
- 27 Jan 2010 New trial record